Yahoo Finance

Gradient Denervation Technologies Enrolls Initial Patient in First-In-Human Study of Pulmonary Artery Denervation Technology

PARIS, FRANCE / ACCESSWIRE / June 1, 2023 / Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive device for treating certain heart failure patients ...
Yahoo Finance

Gradient Denervation Technologies Appoints Stanton Rowe to Board of Directors and Receives FDA Approval to Expand Early Feasibility Study

PARIS, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive, ultrasound-based catheter system designed to treat ...
Business Wire

Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys

PARIS--(BUSINESS WIRE)--Gradient Denervation Technologies (“Gradient”), a medical device company developing an innovative catheter-based solution for the treatment of pulmonary hypertension, announces ...
KTLA

Gradient Denervation Technologies Enrolls First Patient in Early Feasibility Study of Pulmonary Artery Denervation System

PARIS, March 6, 2024 /PRNewswire/ -- Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive, ultrasound-based device designed to treat pulmonary ...
London South East

Gradient Denervation Technologies Initial Patient

Company plans Early Feasibility Study in the US for late 2023 PARIS, FRANCE / ACCESSWIRE / June 1, 2023 / Gradient Denervation Technologies, a Paris-based medical device company developing a minimally ...
Finanznachrichten

Gradient Denervation Technologies Appoints Stanton Rowe to Board of Directors and Receives FDA Approval to Expand Early Feasibility Study

Serial entrepreneur and medical device industry executive adds key experience to board of directors PARIS, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies, a Paris-based medical ...